The independent ISO-certified security testing lab AV-Comparatives has released the results of its Endpoint Prevention and Response Test (EPR)

INNSBRUCK, Austria, Jan. 24, 2022 /PRNewswire/ — The AV-Comparatives EPR test is the most comprehensive assessment of its kind in the world. Like all AV-Comparatives’ public test reports, the 2021 EPR Comparative Report is available for free:…

Nabors Announces New Revolving Credit Facility

HAMILTON, Bermuda, Jan. 24, 2022 /PRNewswire/ — Nabors Industries Ltd. (“Nabors”) (NYSE: NBR) closed, on January 21, 2022, a secured $350 million revolving credit facility maturing on January 21, 2026. The new credit facility replaces the Company’s 2018 Revolving Credit Facility, which…

Gov. Baker Celebrates Educational Opportunity, Proclaims Jan. 23-Jan. 29 “Massachusetts School Choice Week”

BOSTON, Jan. 23, 2022 /PRNewswire/ — “It is important for parents in Massachusetts to explore and identify the best education options available to their children,” reads a proclamation just issued by Gov. Charlie Baker, recognizing this Jan. 23-29 as “Massachusetts School Choice Week.”…

Ascletis Announces First Patient Dosed in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma

HANGZHOU and SHAOXING, China, Jan. 23, 2022 /PRNewswire/ — Ascletis Pharma Inc. (HKEX code: 1672) today announces the dosing of the first patient in the Phase III registration clinical trial of ASC40 combined with bevacizumab for treatment of recurrent glioblastoma (rGBM). ASC40 is an…

CELLCOM ISRAEL LTD. ANNOUNCES EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS

NETANYA, Israel, Jan. 23, 2022 /PRNewswire/ — Cellcom Israel Ltd. (TASE: CEL) announced today that an Extraordinary General Meeting of Shareholders (the “Meeting”) of Cellcom Israel Ltd. (the “Company”) will be held on Monday, February 28, 2022, at 16:00 p.m. (Israel time), at the…

ALERT: Investors in NRx Pharmaceuticals, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – NRXP; NRXPW

SAN DIEGO, Jan. 23, 2022 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP; NRXPW) securities between June 1, 2021 and November 4, 2021, both dates inclusive (the “Class Period”) have until…

Sanya Welcomes Travelers this Spring Festival with an Exciting Lineup of Cultural Activities

SANYA, China, Jan. 22, 2022 /PRNewswire/ — As the world prepares to ring in the Year of the Tiger, the Sanya Tourism Promotion Board (“STPB”) has unveiled its “Fantastic Chinese New Year Sanya Tour” program, which features a wave of exciting cultural activities and events to celebrate…

Rx.Health Goes Enterprise Wide with Yale New Haven Health Aiming to Automate Over 6 Million Patient Encounters Annually

NEW YORK, Jan. 22, 2022 /PRNewswire/ — The largest health system in Connecticut, Yale New Haven Health (YNHHS), has partnered with digital health platform provider Rx.Health to expand and unify their digital health assets. The health system will have access to the EHR-integrated digital…

Halper Sadeh LLP Investigates CCMP, VRS, APR, TSC; Shareholders are Encouraged to Contact the Firm

NEW YORK, Jan. 22, 2022 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: CMC Materials, Inc. (NASDAQ: CCMP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties…

Halper Sadeh LLP Investigates CRHC, SMFR, ZGNX, BFC; Shareholders are Encouraged to Contact the Firm

NEW YORK, Jan. 22, 2022 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cohn Robbins Holdings Corp. (NYSE: CRHC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties…

« Previous Page — Next Page »